nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Blister—Hydroxyurea—brain cancer	0.0345	0.0346	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Procarbazine—brain cancer	0.0267	0.0268	CcSEcCtD
Vildagliptin—Skin exfoliation—Hydroxyurea—brain cancer	0.0237	0.0238	CcSEcCtD
Vildagliptin—Infection—Carboplatin—brain cancer	0.0205	0.0206	CcSEcCtD
Vildagliptin—Pancreatitis—Procarbazine—brain cancer	0.0197	0.0198	CcSEcCtD
Vildagliptin—Skin exfoliation—Carmustine—brain cancer	0.0192	0.0193	CcSEcCtD
Vildagliptin—Dermatitis bullous—Hydroxyurea—brain cancer	0.0189	0.0189	CcSEcCtD
Vildagliptin—Skin exfoliation—Temozolomide—brain cancer	0.0185	0.0186	CcSEcCtD
Vildagliptin—Infection—Lomustine—brain cancer	0.0179	0.018	CcSEcCtD
Vildagliptin—Pancreatitis—Hydroxyurea—brain cancer	0.0153	0.0153	CcSEcCtD
Vildagliptin—Skin exfoliation—Etoposide—brain cancer	0.0148	0.0149	CcSEcCtD
Vildagliptin—Chills—Procarbazine—brain cancer	0.0145	0.0145	CcSEcCtD
Vildagliptin—Weight increased—Hydroxyurea—brain cancer	0.0142	0.0142	CcSEcCtD
Vildagliptin—Infestation—Hydroxyurea—brain cancer	0.0139	0.014	CcSEcCtD
Vildagliptin—Infestation NOS—Hydroxyurea—brain cancer	0.0139	0.014	CcSEcCtD
Vildagliptin—Liver function test abnormal—Carmustine—brain cancer	0.0135	0.0135	CcSEcCtD
Vildagliptin—Tremor—Procarbazine—brain cancer	0.0131	0.0132	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Hydroxyurea—brain cancer	0.0131	0.0132	CcSEcCtD
Vildagliptin—Arthralgia—Procarbazine—brain cancer	0.0119	0.012	CcSEcCtD
Vildagliptin—Oedema—Procarbazine—brain cancer	0.0115	0.0115	CcSEcCtD
Vildagliptin—Infection—Procarbazine—brain cancer	0.0114	0.0114	CcSEcCtD
Vildagliptin—Angiopathy—Hydroxyurea—brain cancer	0.0113	0.0114	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Temozolomide—brain cancer	0.0113	0.0114	CcSEcCtD
Vildagliptin—Chills—Hydroxyurea—brain cancer	0.0112	0.0112	CcSEcCtD
Vildagliptin—Weight increased—Temozolomide—brain cancer	0.0111	0.0111	CcSEcCtD
Vildagliptin—Hyperhidrosis—Procarbazine—brain cancer	0.0111	0.0111	CcSEcCtD
Vildagliptin—Infestation—Temozolomide—brain cancer	0.0109	0.0109	CcSEcCtD
Vildagliptin—Infestation NOS—Temozolomide—brain cancer	0.0109	0.0109	CcSEcCtD
Vildagliptin—Nausea—Lomustine—brain cancer	0.0107	0.0108	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.0104	0.0105	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Temozolomide—brain cancer	0.0103	0.0103	CcSEcCtD
Vildagliptin—Oedema peripheral—Carmustine—brain cancer	0.00993	0.00998	CcSEcCtD
Vildagliptin—Connective tissue disorder—Carmustine—brain cancer	0.00991	0.00995	CcSEcCtD
Vildagliptin—Fatigue—Procarbazine—brain cancer	0.00987	0.00992	CcSEcCtD
Vildagliptin—Constipation—Procarbazine—brain cancer	0.00979	0.00984	CcSEcCtD
Vildagliptin—Hepatitis—Temozolomide—brain cancer	0.00974	0.00979	CcSEcCtD
Vildagliptin—Oedema peripheral—Temozolomide—brain cancer	0.0096	0.00964	CcSEcCtD
Vildagliptin—Connective tissue disorder—Temozolomide—brain cancer	0.00958	0.00962	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00918	0.00922	CcSEcCtD
Vildagliptin—Urticaria—Procarbazine—brain cancer	0.0091	0.00914	CcSEcCtD
Vildagliptin—Oedema—Hydroxyurea—brain cancer	0.00886	0.0089	CcSEcCtD
Vildagliptin—Angiopathy—Temozolomide—brain cancer	0.00884	0.00888	CcSEcCtD
Vildagliptin—Infection—Hydroxyurea—brain cancer	0.0088	0.00884	CcSEcCtD
Vildagliptin—Malnutrition—Carmustine—brain cancer	0.00878	0.00882	CcSEcCtD
Vildagliptin—Chills—Temozolomide—brain cancer	0.00874	0.00878	CcSEcCtD
Vildagliptin—Nervous system disorder—Hydroxyurea—brain cancer	0.00869	0.00873	CcSEcCtD
Vildagliptin—Infestation NOS—Etoposide—brain cancer	0.00869	0.00872	CcSEcCtD
Vildagliptin—Infestation—Etoposide—brain cancer	0.00869	0.00872	CcSEcCtD
Vildagliptin—Skin disorder—Hydroxyurea—brain cancer	0.00861	0.00865	CcSEcCtD
Vildagliptin—Malnutrition—Temozolomide—brain cancer	0.00848	0.00852	CcSEcCtD
Vildagliptin—Tremor—Carmustine—brain cancer	0.00822	0.00826	CcSEcCtD
Vildagliptin—Asthenia—Procarbazine—brain cancer	0.00822	0.00825	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Etoposide—brain cancer	0.00822	0.00825	CcSEcCtD
Vildagliptin—Tremor—Temozolomide—brain cancer	0.00795	0.00798	CcSEcCtD
Vildagliptin—Diarrhoea—Procarbazine—brain cancer	0.00783	0.00787	CcSEcCtD
Vildagliptin—Angioedema—Temozolomide—brain cancer	0.00775	0.00779	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00765	0.00768	CcSEcCtD
Vildagliptin—Fatigue—Hydroxyurea—brain cancer	0.00764	0.00767	CcSEcCtD
Vildagliptin—Constipation—Hydroxyurea—brain cancer	0.00758	0.00761	CcSEcCtD
Vildagliptin—Dizziness—Procarbazine—brain cancer	0.00757	0.00761	CcSEcCtD
Vildagliptin—Arthralgia—Temozolomide—brain cancer	0.00722	0.00725	CcSEcCtD
Vildagliptin—Headache—Procarbazine—brain cancer	0.00717	0.00721	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.00717	0.0072	CcSEcCtD
Vildagliptin—Oedema—Carmustine—brain cancer	0.00716	0.0072	CcSEcCtD
Vildagliptin—Infection—Carmustine—brain cancer	0.00712	0.00715	CcSEcCtD
Vildagliptin—Angiopathy—Etoposide—brain cancer	0.00707	0.00711	CcSEcCtD
Vildagliptin—Chills—Etoposide—brain cancer	0.007	0.00703	CcSEcCtD
Vildagliptin—Oedema—Temozolomide—brain cancer	0.00692	0.00695	CcSEcCtD
Vildagliptin—Infection—Temozolomide—brain cancer	0.00688	0.00691	CcSEcCtD
Vildagliptin—Nausea—Procarbazine—brain cancer	0.0068	0.00683	CcSEcCtD
Vildagliptin—Nervous system disorder—Temozolomide—brain cancer	0.00679	0.00682	CcSEcCtD
Vildagliptin—Skin disorder—Temozolomide—brain cancer	0.00672	0.00675	CcSEcCtD
Vildagliptin—Hyperhidrosis—Temozolomide—brain cancer	0.00669	0.00672	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Carmustine—brain cancer	0.00653	0.00656	CcSEcCtD
Vildagliptin—Asthenia—Hydroxyurea—brain cancer	0.00636	0.00639	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00631	0.00634	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Carmustine—brain cancer	0.00619	0.00621	CcSEcCtD
Vildagliptin—Constipation—Carmustine—brain cancer	0.00613	0.00615	CcSEcCtD
Vildagliptin—Diarrhoea—Hydroxyurea—brain cancer	0.00606	0.00609	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Temozolomide—brain cancer	0.00598	0.006	CcSEcCtD
Vildagliptin—Fatigue—Temozolomide—brain cancer	0.00597	0.006	CcSEcCtD
Vildagliptin—Constipation—Temozolomide—brain cancer	0.00592	0.00595	CcSEcCtD
Vildagliptin—Dizziness—Hydroxyurea—brain cancer	0.00586	0.00589	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00574	0.00576	CcSEcCtD
Vildagliptin—Headache—Hydroxyurea—brain cancer	0.00555	0.00558	CcSEcCtD
Vildagliptin—Infection—Etoposide—brain cancer	0.0055	0.00553	CcSEcCtD
Vildagliptin—Urticaria—Temozolomide—brain cancer	0.0055	0.00552	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—brain cancer	0.00538	0.0054	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—brain cancer	0.00536	0.00538	CcSEcCtD
Vildagliptin—Nausea—Hydroxyurea—brain cancer	0.00526	0.00529	CcSEcCtD
Vildagliptin—Asthenia—Carmustine—brain cancer	0.00514	0.00516	CcSEcCtD
Vildagliptin—Asthenia—Temozolomide—brain cancer	0.00497	0.00499	CcSEcCtD
Vildagliptin—Diarrhoea—Carmustine—brain cancer	0.0049	0.00492	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—brain cancer	0.00478	0.0048	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—brain cancer	0.00478	0.0048	CcSEcCtD
Vildagliptin—Dizziness—Carmustine—brain cancer	0.00474	0.00476	CcSEcCtD
Vildagliptin—Constipation—Etoposide—brain cancer	0.00474	0.00476	CcSEcCtD
Vildagliptin—Diarrhoea—Temozolomide—brain cancer	0.00474	0.00476	CcSEcCtD
Vildagliptin—Dizziness—Temozolomide—brain cancer	0.00458	0.0046	CcSEcCtD
Vildagliptin—Headache—Carmustine—brain cancer	0.00449	0.00451	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—brain cancer	0.0044	0.00442	CcSEcCtD
Vildagliptin—Headache—Temozolomide—brain cancer	0.00434	0.00436	CcSEcCtD
Vildagliptin—Nausea—Carmustine—brain cancer	0.00426	0.00427	CcSEcCtD
Vildagliptin—Nausea—Temozolomide—brain cancer	0.00411	0.00413	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—brain cancer	0.00397	0.00399	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—brain cancer	0.00379	0.00381	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—brain cancer	0.00366	0.00368	CcSEcCtD
Vildagliptin—Headache—Etoposide—brain cancer	0.00347	0.00349	CcSEcCtD
Vildagliptin—Nausea—Etoposide—brain cancer	0.00329	0.00331	CcSEcCtD
Vildagliptin—DPP9—pituitary gland—brain cancer	0.00103	0.234	CbGeAlD
Vildagliptin—DPP4—blood vessel—brain cancer	0.000993	0.227	CbGeAlD
Vildagliptin—DPP9—cerebellum—brain cancer	0.0007	0.16	CbGeAlD
Vildagliptin—DPP9—brain—brain cancer	0.000569	0.13	CbGeAlD
Vildagliptin—DPP4—endocrine gland—brain cancer	0.000304	0.0693	CbGeAlD
Vildagliptin—DPP4—head—brain cancer	0.0003	0.0684	CbGeAlD
Vildagliptin—DPP4—central nervous system—brain cancer	0.000274	0.0625	CbGeAlD
Vildagliptin—DPP4—brain—brain cancer	0.000217	0.0496	CbGeAlD
